ArriVent BioPharma Inc (AVBP)
NASDAQ
The current AVBP market cap is 822.55M. The company's latest EPS is USD -2.0575 and P/E is -11.87.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|
USD ($) | USD ($) | |||
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -23.12M | -20.67M | -25.7M | -24.23M |
Net Income | -21.19M | -17.42M | -21.87M | -20.56M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 0 | 0 |
Operating Income | -36.91M | -74.59M |
Net Income | -36.91M | -69.33M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|
USD ($) | USD ($) | |||
Total Assets | 163.1M | 327.84M | 308.86M | 292.71M |
Total Liabilities | 11.8M | 10.12M | 12.2M | 15.22M |
Total Equity | -153.19M | 317.72M | 296.66M | 277.49M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 182.83M | 163.1M |
Total Liabilities | 8.37M | 11.8M |
Total Equity | -85.11M | -153.19M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|
USD ($) | USD ($) | |||
Operating | -55.84M | -18.63M | -37.72M | -54.06M |
Investing | N/A | N/A | N/A | N/A |
Financing | 42.86M | 185.63M | 186M | 186.53M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Operating | -43.63M | -55.84M |
Investing | N/A | N/A |
Financing | 169.72M | 42.86M |
Market Cap | 822.55M |
Price to Earnings Ratio | -11.87 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 5.47 |
Price to Book Ratio | 5.44 |
Dividend Yield | - |
Shares Outstanding | 33.7M |
Average Volume (1 week) | 148.82k |
Average Volume (1 Month) | 158.3k |
52 Week Change | 1.71% |
52 Week High | 36.37 |
52 Week Low | 14.35 |
Spread (Intraday) | 5.62 (19.49%) |
Company Name | ArriVent BioPharma Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://arrivent.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.